Symptom dimensions of depression and anxiety and the metabolic syndrome

Psychosomatic Medicine

Volumn 73, Issue 3, 2011, Pages 257-264

  Luppino, Floriana S ^a   Van Reedt Dortland, Arianne K B ^a   Wardenaar, Klaas J ^a   Bouvy, Paul F ^c   Giltay, Erik J ^a   Zitman, Frans G ^a,b   Penninx, Brenda W J H ^a,d,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGZ Rivierduinen   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

anxiety; depression; metabolic syndrome; symptom dimensions

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANXIETY DISORDER; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NETHERLANDS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; QUESTIONNAIRE; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 79954871933     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31820a59c0     Document Type: Article

References (61)

1. Penninx BW, Beekman AT, Honig A, Deeg DJ, Schoevers RA, van Eijk JT, van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58: 221-7. (Pubitemid 32209674)
2. Barth J, Schumacher M, Herrmann-Lingen C Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004;66:802-13. (Pubitemid 39552862)
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52. (Pubitemid 41532612)
4. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001;2:73-86. (Pubitemid 33755917)
5. Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamaki HT. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006;67: 1422-7. (Pubitemid 44583390)
6. Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxi-ety, depression, and the metabolic syndrome. Biol Psychiatry 2007;62: 1251-7. (Pubitemid 350060887)
7. Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry 2009;66:91-3.
8. Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010;122:30-9.
9. Ierodiakonou CS, Iacovides A. Somatic manifestations of depressive patients in different psychiatric settings. Psychopathology 1987;20: 136-43. (Pubitemid 18060635)
10. Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009;17:889-98.
11. Franko DL, Striegel-Moore RH, Thompson D, Schreiber GB, Daniels SR. Does adolescent depression predict obesity in black and white young adult women? Psychol Med 2005;35:1505-13. (Pubitemid 41430687)
12. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Vanhala M. De-pressive symptoms and 10-year risk for cardiovascular morbidity and mortality. World J Biol Psychiatry 2010;11:834-9.
13. Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of the metabolic syndrome in mid-dle-aged women. Psychosom Med 2009;71:266-72.
14. Goldberg D. A dimensional model for common mental disorders. Br J Psychiatry 1996;Suppl:44-9. (Pubitemid 26179805)
15. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Associ-ation and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304. (Pubitemid 41242486)
16. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-8. (Pubitemid 40740871)
17. Toker S, Shirom A, Melamed S. Depression and the metabolic syndrome: gender-dependent associations. Depress Anxiety 2008;25:661-9.
18. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93:1976-80. (Pubitemid 26165560)
19. Frasure-Smith N, Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67 Suppl 1:S19-S25. (Pubitemid 40721027)
20. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Preva-lence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617-27. (Pubitemid 40973437)
21. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001;110:585-99. (Pubitemid 33049422)
22. Veen G, van Vliet IM, Derijk RH, Giltay EJ, van Pelt J, Zitman FG. Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety. Psychiatry Res 2011;185:121-8.
23. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods 2002;7: 19-40.
24. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol1991; 100:316-36.
25. de Beurs E, Hollander-Gijsman ME, Helmich S, Zitman F. The tripartite model for assessing symptoms of anxiety and depression: psychometrics of the Dutch version of the mood and anxiety symptoms questionnaire. Behav Res Ther 2007;45:1609-17. (Pubitemid 46669430)
26. Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCor-mick RA. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Ab-norm Psychol 1995;104:3-14.
27. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, Cuijpers P, de Jong PJ, van Marwijk HW, Assendelft WJ, van der Meer K, Verhaak P, Wensing M, de Graaf R, Hoogendijk WJ, Ormel J, van Dyck R. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008;17: 121-40.
28. Watson D, Clark LA, Weber K, Assenheimer JS, Strauss ME, McCor-mick RA. Testing atripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples. J Ab-norm Psychol 1995;104:15-25.
29. Chorpita BF, Daleiden EL. Tripartite dimensions of emotion in a child clinical sample: measurement strategies and implications for clinical utility. J Consult Clin Psychol 2002;70:1150-60.
30. Wardenaar KJ, van Veen T, Giltay EJ, de Beurs E, Penninx BW, Zitman FG. Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ). Psychiatry Res 2010;179:101-6.
31. Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). Am J Cardiol 2003;91:667-72. (Pubitemid 36287455)
32. Grundy SM, Vega GL, Yuan Z, Battisti WP, Brady WE, Palmisano J. Effectiveness and tolerability of simvastatin plus fenofibrate for com-bined hyperlipidemia (the SAFARI trial). Am J Cardiol 2005;95:462-8. (Pubitemid 40247539)
33. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW. Hypercor-tisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007;32:151-9 (Pubitemid 46274017)
34. SHEP Cooperative Research Group. Prevention of stroke by antihyper-tensive drug treatment in older persons with isolated systolic hyperten-sion. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-64.
35. Tannen RL, Weiner MG, Marcus SM. Simulation of the Syst-Eur ran-domized control trial using a primary care electronic medical record was feasible. J Clin Epidemiol 2006;59:254-64. (Pubitemid 43243651)
36. Beck AT, Epstein N, Brown G, Steers RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56:893-7. (Pubitemid 19008360)
37. IDS/QIDS. Inventory of depressive symptomatology (IDS) & Quick Inventory of Depressive Symptomatology (QIDS). Available at http://www.ids-qids. org/index2.html#table3. Accessed January 5, 2011.
38. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport 2000;71:S114-20.
39. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification. WHO 2009.
40. Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004;66:316-22. (Pubitemid 38668398)
41. Wardenaar KJ, van Veen T, Giltay EJ, Hollander-Gijsman M, Penninx BW, Zitman FG. The structure and dimensionality of the Inventory of Depressive Symptomatology Self Report (IDS-SR) in patients with de-pressive disorders and healthy controls. J Affect Disord 2010;125: 146-54.
42. De Jonge P, Ormel J, van den Brink RH, van Melle JP, Spijkerman TA, Kuijper A, van Veldhuisen DJ, van den Berg MP, Honig A, Crijns HJ Schene AH. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardio-vascular prognosis. Am J Psychiatry 2006;163:138-44. (Pubitemid 43050115)
43. Bosch NM, Riese H, Dietrich A, Ormel J, Verhulst FC, Oldehinkel AJ. Preadolescents' somatic and cognitive-affective depressive symptoms are differentially related to cardiac autonomic function and cortisol: the TRAILS study. Psychosom Med 2009;71:944-50.
44. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86.
45. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 2004;55:1-9. (Pubitemid 38045427)
46. Vreeburg SA, Hoogendijk WJ, van Pelt J, de Rijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009;66:617-26.
47. Licht CM, Vreeburg SA, Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, de Rijk RH, Vogelzangs N, Zitman FG, de Geus EJ, Penninx BW. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010;95:2458-66.
48. Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008;106:249-55.
49. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24 Suppl 2:S50-5. (Pubitemid 30461948)
50. Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, ComijsHC, Hoogendijk WJ, Deeg DJ, Penninx BW. Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry 2009;17:716-21.
51. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 2007;49:27-33. (Pubitemid 46360337)
52. Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, Lambert G. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010;28:543-50.
53. Mast BT, Miles T, Penninx BW, Yaffe K, Rosano C, Satterfield S, Ayonayon HN, Harris T, Simonsick EM. Vascular disease and future risk of depressive symptomatology in older adults: findings from the health, aging, and body composition study. Biol Psychiatry 2008;64:320-6.
54. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-22. (Pubitemid 128719702)
55. Steffens DC, Krishnan KR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 2002;33:1636-44. (Pubitemid 34619971)
56. Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, Miller J, Thomas MA, Kumar A. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic reso-nance spectroscopy. Neuropsychopharmacology 2007;32:1224-31. (Pubitemid 46788852)
57. Huber JD. Diabetes, cognitive function, and the blood-brain barrier. Curr Pharm Des 2008;14:1594-600. (Pubitemid 352002986)
58. LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, Blair SN. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study ofmen and women. Circulation 2005;112:505-12. (Pubitemid 41060790)
59. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-78. (Pubitemid 35386892)
60. Ingram DG. Is the metabolic syndrome a discrete diagnostic category or the end of a continuum? Taxometric evidence for dimensionality in the National Health and Nutrition Examination Survey 1999-2004. Ann Epidemiol 2009;19:143-7.
61. Hollander-Gijsman ME, de Beurs E, van der Wee NJ, van Rood YR, Zitman FG. Distinguishing between depression and anxiety: a proposal for an extension ofthe tripartite model. EurPsychiatry 2010;25:197-205.